SEC Filings

8-K
PERNIX THERAPEUTICS HOLDINGS, INC. filed this Form 8-K on 11/13/2018
Entire Document
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

PERNIX THERAPEUTICS HOLDINGS, INC.

 

 

 

 

 

Date:  November 8, 2018

By:

/s/ Angus W. Smith

 

 

 

Angus W. Smith

 

 

 

Senior Vice President and Chief Business Officer and Principal Financial Officer
(Principal Financial Officer)